The Future of PET Dynamic vs static imaging

Transcription

1 The 5th Uppsala Spring Meeting The Future of PET Dynamic vs static imaging April 6-8, 2009 Uppsala, Sweden

2 Refresher course Monday April 06, Welcome The GEHC Academic initiative The Uppsala University MI vision The GEHC MI vision The Uppsala ASL In vitro cell imaging techniques Life science technology In vitro tissue imaging techniques Data interpretation tissue-animal-man Data handling - data collection interpretation GEHC Radio tracer platforms 11 C-tracers 68 Ga tracers 18 F-tracers Scanners and the future development The clinical needs and where to go Tracer development technology/science. Why and how Bengt Nielsen and Bengt Nielsen Britt Skogseid Jeanluc Vanderheyden Erik Strömqvist Azita Monazzam Åsa Hagner-McWhirter Håkan Hall Pasha Razifar Lennart Thurfjell Johan Ulin Oleksiy Itsenko Irina Velikyan Obaidur Rahman Alec Ganin Dinner Faculty

3 SYMPOSIUM: The Future of PET TUESday April 07, Future technology in tracer development and biomarkers Biacore technology Maldi imaging and profiling The affibody concept Small molecule binders Optical in vivo technology Stefan Löfås Per Andren Lars Abrahamsen Lars Balzer Len Fass PET and other modalities in the clinics PET and SPECT in MI 68 Ga-tracers in the clinics PET/ MR/ NM/ Ultrasound/ Photonics: the ultimate solution diagnostics and therapy Mono clonal and bi-specific Antibodies MI in diagnostics and treatment - where to go Helmuth Maecke Vikas Prasad Andreas Melzer David Goldenberg Steven Larson Lunch Activation studies Social Phobia and genetics Pharmacological MRI, a new way to visualise drug action in the brain PK/PD modelling in dug development Efflux system in tracer development Mats Fredriksson Steve Williams Mats Bergström Yasuyoshi Watanabe The hurdles in development of diagnostics and drugs The renaissance of the risk-benefit concept The toxicology GMP ex-tempore contra industrial The microdosing concept - why and where Jurgen Borlack Per Hartvig Anders Grahnen The pharma visions/expectations Pfizer GSK Roche The regulatory perspective Discussion Tbd Mats Bergström Raymond Josephsson Ulla Wändel-Liminga Buffet dinner

4 The Future Technology in Tracer Development and Biomakers WEDNESday April 08, PET in dementia research tracers and neuropsychology PET in AD/PD and inflammation An Australian experience in MI and the directions Gallgas and tracers for lung studies Agneta Nordberg David Brooks Rodney Hicks Göran Hedenstierna MI and MRI/MS in the clinics - where to go PET in the clinics, a Scandinavian perspective Clinical PET in adrenal disorders / cancer Clinical PET in endocrine disorders / cancer Clincal PET at KS, Stockholm Clinical PET in Turku Clinical PET in Odense Clinical PET in Uppsala Summary and close Marcus Schwaiger Barbro Eriksson Stig Larsson Marko Seppänen Poul Flemming Høilund-Carlsen Jens Sörensen Terri Bresenham Lunch

5 REGISTRATION The 5th Uppsala Spring Meeting April 6-8, 2009 Uppsala Konsert & kongress center ( Vaksala torg 1, Uppsala, Sweden We need your registration no later than March 26, 2009 Name:... Title:... Clinic:... Address:... Country:... Phone no:... address:... Kindly specify which programs you will attend: Day 1, April 06 Day 2, April 07 Day 3, April 08 Register via fax or mail: Fax [email protected] The participation fee is 1000 SEK (approx. 115 US dollars) for the whole event and includes all meals as per the program. Your application is registered when the fee is paid to: Danske Bank, Account no: SWIFT: DABASESX IBAN: SE Please add your name and USM09 as reference for the payment. For questions regarding payment, please contact Sungmee Gundlegard via [email protected] Hotel suggestions: Park Inn Uppsala, Phone , Scandic Upplandia, Phone , Hotel Gillet, Phone , First Hotel Linné, Phone

6 AFFILIATIONS Terri Bresenham Bengt Nielsen Jeanluc Vanderheyden Erik Strömqvist Irina Velikyan Azita Monazzam Håkan Hall Hagner-McWhirter, Asa Pasha Razifar Oleksiy Itsenko Obaidur Rahman Johan Ulin Alec Ganin Agneta Nordberg Davdi Brooks Rodney Hicks Helmuth Maecke Vikas Prasad Andreas Melzer David Goldenberg Steven Larson Mats Fredriksson Steve Williams Mats Bergström Yasuyoshi Watanabe Jurgen Borlack Anders Grahnen Per Hartvig Raymond Josephsson Ulla Wändel-Liminga Stefan Löfås Per Andren Åsa Hagner-McWhirter Lars Abrahamsen Lars Balzer Göran Hedenstierna Marcus Schwaiger Barbro Eriksson Stig Larsson Poul Flemming Høilund- Carlsen Marko Seppänen JENS SÖRENSEN VP Molecular Imaging, GE Healthcare, Milwaukee Ph.D Academic Programs, GE Healthcare, Stockholm Ph.D Molecular Imaging, GE Healthcare Milwaukee MD, GEMS PET Systems AB, Uppsala Ass. Prof. Uppsala Applied Science Lab, Uppsala Ph.D GE Healthcare Life Science, Uppsala BSc, Uppsala Applied Science Lab, Uppsala Chief Engineer Molecular Imaging, Milwaukee Prof. Karolinska Institutet, Stockholm Prof. Karolinska Institutet, Stockholm Prof. Imperial College, London Prof. Peter McCullum Cancer Institute, Melbourne Prof. Institute of Nuclear Medicine, Basel Dr. Zentralklinik, Bad Berka Prof. University of Dundee, UK MD. Garden State Cancer Center, New Jersey Prof.Memorial Sloane Kettering, New York, Uppsala Prof. King s College, London Prof. GSK, London Prof. Riken CMIS, Kobe, Japan, Uppsala Prof. Fraunhofer Instiitute, Hannover Prof. Quintile, Uppsala Prof. Rigshospitalet, Copenhagen Ph.D. Roche, Basel Ph.D. Scientific Director Pharmacology / Toxicology at the Medical Products Agency, Sweden. Ph.D. Life Science, Uppsala Ph.D, GE Healthcare Life Science, Uppsala Ph.D. Affibody, Stockholm Prof. Em. Uppsala University Prof. TUM, Münich Pof. Karolinska Sjukhuset, Stockholm Prof. Karolinska Hospital, Stockholm Prof. Odense University Hospitalet, Odense Docent. University Hospital, Turku Dr. Head of the Nuc Med Academic Hospital, Uppsala [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected]